←
Michael J. Lee712 posts
Michael J. Lee avatar

Michael J. Lee

@TheLeeLab

A Laboratory of Systems Pharmacology

◷ Joined September 2013▧ 102 Photos and videos
Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

The answer is about analytical resolution!!! The way we measure drug responses makes drug-induced growth rates and death rates very clear. More conventional approaches just can't see these distinctions clearly, masking this crazy phenotype. (8/end)

Post attachment
Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

There is lots of cool stuff to work on moving forward, but I'll end by highlighting why we found this, when so many others probably could have but didn't notice. (7/n)

Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

We identified many clinically used drugs that owe their lethality to a PDAR-dependent cell death. Many of these are not conventionally thought of as transcriptional inhibitors! (6/n)

Post attachment
Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

We did a genetic screen to identify regulators of this death response... We call this response PDAR: The Pol II Degradation-dependent Apoptotic Response. (5/n)

Post attachment
Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

It's challenging to uncouple Pol II expression from Pol II activity (Pol II activity creates Pol II expression) but we managed! We did many things, but the most notable is that we suppressed lethality caused by loss of Pol II by giving cells a non-functional form of Pol II! (4/n)

Post attachment
Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

We spent a lot of time trying to rationalize this through the decay rates of certain transcripts/proteins, but it never worked. The big 'ah-ha' was when we noticed that variation in death kinetics was perfectly coupled to variation in theloss of the inactive form of Pol II (3/n)

Post attachment
Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

we first noticed that death following loss of Pol II is only apoptotic. This is surprising, considering that there are many other ways for cells to "waste away" in the absence of gene expression... but, cells that can't do apoptosis just sit there. pretty happily in fact (2/n)

Post attachment
Michael J. Lee avatar
Michael J. Lee@TheLeeLab·13 Dec 2024

We just posted a preprint about a death mechanism that we find truly surprising. When you turn off transcription, cells die (duh!) but did you know this happens due to loss of Pol II itself, not loss of Pol II activity! preprint here and a thread (1/n): biorxiv.org/content/10.1101/…

Michael J. Lee avatar
Michael J. Lee@TheLeeLab·29 Oct 2024

The SACB Abstract deadline is this Friday. This is an awesome community and always a very engaging meeting. Join us in Colorado this February!

Abstracts are due this Friday for #SACB2025! A great meeting for those who are employing systems approaches in cancer. We have an incredible array of speakers and a fantastic new location near Denver, Colorado.

Post attachment
CancerSystemsBiology avatar
⟳ Michael J. Lee retweeted
CancerSystemsBiology@CancerSysBio·22 Oct 2024

Systems approaches to cancer biology meeting (SACB2025) is coming up! The abstract deadline and application to be part of our SACB 2025 Scholar program is Friday, November 1. Check out the details at sacbmeeting.org

Michael Yaffe avatar
⟳ Michael J. Lee retweeted
Michael Yaffe@mbyaffe·8 Oct 2024

Thrilled to share our latest story on 5-FU inducing RNA damage during ribosome biogenesis - cell.com/cell-reports-medici…. The whole thing started when Karl and Jung-Kuei were trying to figure out hiow limiting dNTPS skewed DNA repair. Never thought it would be RNA and tge ribosome!